Classification of 'Fludeoxyglucose' (FDG) under Central Excise Tariff Act: AAR ruling clarifies

The Authority for Advance Ruling (AAR) determined that 'Fludeoxyglucose' (FDG) is not classifiable under Chapter 3006 3000 of the Central Excise Tariff Act, 1985, but falls under heading 2844 4000, which covers radioactive isotopes and their compounds. The AAR declined to address the general question on the classification of chemicals used as pharmaceuticals under Chapters 28 & 29 versus Chapter 30, as it lacked specificity regarding a particular product.

---

---

Issues Involved:
1. Classification of 'Fludeoxyglucose' or 'FDG' under Chapter 3006 3000 of the Central Excise Tariff Act, 1985.
2. Classification of chemicals used as pharmaceuticals under Chapters 28 & 29 versus Chapter 30.

Issue-Wise Detailed Analysis:

Issue 1: Classification of 'Fludeoxyglucose' or 'FDG'
The applicant, engaged in manufacturing FDG, sought clarification on whether FDG should be classified under Chapter 3006 3000 of the Central Excise Tariff Act, 1985. The applicant argued that FDG, being a radiopharmaceutical used in PET imaging, should be classified under Chapter 30, specifically under sub-heading 3006 3000, which covers diagnostic reagents designed to be administered to patients.

The applicant's contention was based on the following points:
1. FDG is a pharmaceutical product used for medical purposes, thus meriting classification under Chapter 30.
2. Note 2 of Section VI of CETA 1985 states that goods classifiable under specific headings like 3004, 3005, 3006, etc., by reason of being put up in measured doses or for retail sale, should be classified in those headings and not under any other heading.
3. FDG meets the criteria of HSN explanatory notes for Chapter 30, which include diagnostic reagents administered to patients.

The concerned officer, however, argued that FDG should be classified under Chapter 2844 4000, which covers radioactive chemical elements and isotopes and their compounds. The officer cited:
1. Section Note 1(A) of Section VI of CETA 1985, which mandates that goods falling under heading 2844 or 2845 should be classified in those headings only.
2. The product FDG is a radioisotope obtained through a cyclotron and fits the description under Chapter 2844 4000.
3. HSN explanatory notes clarify that radioactive isotopes and their compounds, including those used in medicine, fall under heading 2844.

The Authority for Advance Ruling (AAR) observed that FDG is a compound of the radioisotope 18F and thus falls under heading 2844, which covers radioactive isotopes and their compounds. The AAR noted that:
1. General Note 1 of Section VI specifies that radioactive chemical elements and their compounds are classified under heading 2844, even if they could fall under other headings.
2. The diagnostic reagents covered by heading 3006 are those administered to patients, but radioactive isotopes and their compounds remain classified under heading 2844.

Judgment:
The AAR concluded that FDG is not classifiable under Chapter 3006 3000 of the Central Excise Tariff Act, 1985. Instead, it falls under heading 2844 4000.

Issue 2: Classification of Chemicals Used as Pharmaceuticals
The applicant queried whether chemicals used as pharmaceuticals that are inorganic or organic should be classified only under Chapters 28 & 29 and not under Chapter 30, which is specifically for chemical pharmaceuticals.

The AAR noted that the classification of every product is distinct and should be determined based on the applicable provisions, rules of interpretation, and specific product characteristics. The question posed was of a general nature and not specific to any particular product, making it unsuitable for advance ruling under section 98 of the GST Act.

Judgment:
The AAR did not entertain the general question regarding the classification of chemicals used as pharmaceuticals under Chapters 28 & 29 versus Chapter 30, as it did not pertain to a specific product.

Order:
1. FDG is not classifiable under Chapter 3006 3000 of the Central Excise Tariff Act, 1985.
2. The general question on the classification of chemicals used as pharmaceuticals was not entertained under section 98 of the GST Act.

---